The expression of c-erbB-2 and p53 proteins showed a large variation between the non-neoplastic ducts and ductal carcinoma in situ components, but most of the cases showed very similar protein expression and good nuclear grade agreement between ductal carcinoma in situ and invasive ductal carcinoma components. This evidence concerns the gene TP53 and ductal breast carcinoma in situ.